Effects of ELAVl and CDOA vs Upper Thoracic Mobilization on Forward Head Posture in Upper Cross Syndrome

December 13, 2024 updated by: Muhammad Naveed Babur, Superior University

Effects of Elongation Longitudinaux Articular Vertebral and Columnar Decoaption Osteo-articulaire Versus Upper Thoracic Mobilization on Forward Head Posture in Upper Cross Syndrome

This randomized controlled study will examine the patient of forward head posture who suffering with upper cross syndrome. There will be comparison of two treatment methods 1st one is elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA and 2nd is upper thoracic mobilization .

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

This study includes 42 participants, both male and female, age between 20 to 45. ELDOA target the cervical and upper thoracic spine to improve range of motion, restore normal cervical and thoracic spine alignment and reduce muscle tension. Upper thoracic mobilization improve thoracic spine mobility and enhance cervical spine alignment.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Faisalābad, Punjab, Pakistan
        • Allied hospital, Masjid ismail Rd

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult between (20 to 45 year) with upper cross syndrome
  • CVA angle less than 48-50 degrees.
  • No history of spinal injury and fracture
  • limited cervical range of motion

Exclusion Criteria:

  • Severe spinal degeneration or deformity
  • Injury or surgery
  • Cervical radiculopathy
  • Severe osteoporosis
  • Malignancy of upper extremity of thorax
  • Obesity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional group I
Diagnostic test: Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA
ELDOA targtes cervical and upper thoracic spine. ELDOA exercises involves spicific postural holds that improve forward neck posture.The goal of ELDOA is to help reduce stress and increase space in the vertebral joints so that muscles can move freely. The benefits of these stretches include joint mobility, increased fluid absorption in the discs of the spine, flexibility, improved muscle tone, postural alignment, body-mind connection, and coordination. The tension and release created by these stretches helps normalize the posture.
Active Comparator: Interventional group II
Diagnostic test: upper thoracic mobilization
Upper thoracic mobilization, often known as joint mobilization, is a common technique in manual therapy. In order to preserve or restore joint mobility, this approach glides and uses distraction on the joint surfaces.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tragus to wall test
Time Frame: 12 Months
Tragus to wall test for forward head posture assessment: normal below 10 centimetres , 10.1- 12 centimetres for mild positive forward head posture,12.1-15 centimetres moderate forward head posture, less than 15 centimetres severe forward head posture.
12 Months
Craniovertebral angle assess
Time Frame: 12 Months
Craniovertebral angle assess by web plot digitizer software: normal CVA value 48-50 degree, positive forward head posture less than 48 degree
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Superior University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Actual)

September 1, 2024

Study Completion (Estimated)

February 28, 2025

Study Registration Dates

First Submitted

December 13, 2024

First Submitted That Met QC Criteria

December 13, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 13, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MSRSW/Batch-Fall22/767

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cross Syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe